We also compared the ratios of KYN/TRP (reflecting IDO1 activity) and 3-HK/KA (reflecting neurotoxic indices)38, 39 between depression (+) and depression (−) patients during IFN-α therapy (Fig. 1b and Table 3). This evidence concerns the gene IDO1 and depressive symptom measurement.